MicroPort CardioFlow Switches Reporting Currency to U.S. Dollars

MicroPort CardioFlow Medtech Corp. ( (HK:2160) ) just unveiled an announcement.

MicroPort CardioFlow Medtech Corporation has announced it will change the presentation currency of its consolidated financial statements from Renminbi to U.S. dollars, reflecting the growing contribution of MicroPort Cardiac Rhythm Management Limited, whose reporting currency is USD. The board says the move supports the Group’s globalization strategy, aims to give shareholders and potential investors a clearer view of its financial performance, and is not expected to have a material impact on the financial statements as prior-year figures will be restated in USD starting with the 2025 annual report.

The most recent analyst rating on (HK:2160) stock is a Hold with a HK$0.76 price target. To see the full list of analyst forecasts on MicroPort CardioFlow Medtech Corp. stock, see the HK:2160 Stock Forecast page.

More about MicroPort CardioFlow Medtech Corp.

MicroPort CardioFlow Medtech Corporation is a Cayman Islands–incorporated medical technology company listed in Hong Kong that operates through subsidiaries in the cardiovascular sector. The Group focuses on cardiac-related therapies and devices, and is pursuing a globalization strategy, including an expanded presence through its cardiac rhythm management business, which reports in U.S. dollars.

Average Trading Volume: 1,955,318

Technical Sentiment Signal: Sell

Current Market Cap: HK$4.61B

See more data about 2160 stock on TipRanks’ Stock Analysis page.